A Phase 1 Study of CS-3150 Evaluation of Safety, Pharmacokinetics, and Pharmacodynamics after Multiple Oral Administration in Japanese Healthy Adult Male Subjects

Trial Profile

A Phase 1 Study of CS-3150 Evaluation of Safety, Pharmacokinetics, and Pharmacodynamics after Multiple Oral Administration in Japanese Healthy Adult Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Dec 2016

At a glance

  • Drugs Esaxerenone (Primary)
  • Indications Diabetic nephropathies; Essential hypertension; Hyperaldosteronism; Hypertension
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 27 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top